Pneumonia

July 7, 2016July 7, 2016

No Link Found Between Fewer Antibiotics Prescriptions and Increase in Bacterial Infections, Researchers Say

News, Pneumonia

According to recent research, reducing the number of prescriptions of antibiotics for respiratory tract infections, such as sore throats, colds, coughs, and ear infections, is not associated with an increase in ... Read more

July 6, 2016July 6, 2016

Ibuprofen, Inhaled at High Doses, May Be a Way of Treating Cystic Fibrosis

Cystic Fibrosis, News, Pneumonia

You have probably heard of ibuprofen, a common drug-store medication to help with headaches or sprained ankles. Ibuprofen is an anti-inflammatory drug, which is also one of the reasons it ... Read more

July 5, 2016July 5, 2016

‘Hospital at Home’ Is Effective Alternative for Elderly Lung Disease Patients in UK, Research Indicates

COPD, News, Pneumonia

The rate of admissions in elderly patients to acute hospital care in the United Kingdom has increased by 65 percent in the last decade, placing increased labor and cost demands on hospital ... Read more

July 1, 2016July 1, 2016

New Vaccine Against Pneumococcal Lung Infections Deemed Safe, Triggers Immune Response

News, Pneumonia

A new vaccine against pneumococcal lung infections can safely be used in humans and is able to trigger an immune reaction, reports ImmunoBiology Ltd.

June 29, 2016June 29, 2016

PH Associated Idiopathic Interstitial Pneumonias: EMA Says ‘No’ to Adempas (Riociguat)

News, Pneumonia, Pulmonary Hypertension

The European Medicines Agency (EMA) has recommended against Adempas (riociguat) for patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonia (PH-IIP), according to a recent press release. EMA’s recommendation follows Bayer Pharmaceuticals‘ announcement in May for ... Read more

June 23, 2016June 23, 2016

Positive Data on Lefamulin for CAB Pneumonia Presented by Nabriva

News, Pneumonia

Nabriva Therapeutics AG recently announced new research findings for its lead product candidate lefamulin, the first pleuromutilin antibiotic available for systemic administration in humans. The company is developing both intravenous and ... Read more

June 20, 2016June 20, 2016

Novel Vaccine Monitors Bacteria, Acts Only If It Poses Threat, According to Animal Study

News, Pneumonia

A new research study titled “Directed vaccination against pneumococcal disease” recently published in the Proceedings of the National Academy of Sciences (PNAS) journal, described a novel vaccine that allows bacteria responsible for ... Read more

June 13, 2016June 13, 2016

Solithromycin for Community Acquired Pneumonia Shows Positive Phase 2 Results

News, Pneumonia

Data from a Phase 2 clincial trial for solithromycin, a next-generation oral and intravenous fluoroketolide for the treatment of moderate to moderately-severe community acquired bacterial pneumonia (CABP) and urethritis, ... Read more

June 9, 2016June 9, 2016

Philips and Grand Challenges Canada Collaborate to Address Global Childhood Pneumonia

News, Pneumonia

Amsterdam-based Royal Philips and the Toronto, Canada advocacy and funding organization Grand Challenges Canada (GCC) are collaborating on an innovative project to improve childhood pneumonia diagnoses in low-resource countries. The announcement ... Read more

June 2, 2016June 2, 2016

Acute Respiratory Distress Syndrome Is Focus of $3M Research Grant

News, Pneumonia

Dr. David Dean at the University of Rochester Medical Center received a $3 million grant covering four years of research from the National Institutes of Health for the study and development ... Read more